Defopharma SRL
Defopharma reported total assets of 181,427 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Oct 2026).
The score of Defopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +77 % Total assets +11 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Defopharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Oct 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 16 Oct 2024
- Year ended 31 Dec 2021filed on 17 Jun 2022
- Year ended 31 Dec 2020filed on 27 Aug 2021
Defopharma's financial analysis
- Solvency46.8%sector median: 49.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Defopharma
Defopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0732.501.933
- VAT number
- BE0732501933
- Peppol
- Registered · 0208:0732501933 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Aug 2019
- Registered office
- 7860 Lessines
- Latest accounts
- 2025 · filed on 22 Oct 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Defopharma (SRL) has been based in Lessines since 2019, active in: business and other management consultancy activities. For 2025, it reports a net profit of 18,298 € and equity of 84,881 €; its revenue is not published. Its solvency stands at 46.8%, below the median of its sector (49.1%).
Companies similar to Defopharma
Companies in the same business, of comparable size and area, outside its group.
- REZA Business and other management consultancy activities Deinze · balance sheet 181,332 €
- Cedu Wine Business and other management consultancy activities Grimbergen · balance sheet 181,815 €
- Quent.Invest.Consult Business and other management consultancy activities Brussels · balance sheet 180,712 €
- Lobco Business and other management consultancy activities Edegem · balance sheet 180,667 €
- Detroz Management Business and other management consultancy activities Comblain-au-Pont · balance sheet 180,523 €
- Wellness Consult Business and other management consultancy activities Tessenderlo-Ham · balance sheet 180,489 €
- Clean Concept Business and other management consultancy activities Silly · balance sheet 182,372 €
- Home Management Business and other management consultancy activities Anderlecht · balance sheet 179,358 €
Frequently asked questions about Defopharma
What is the revenue of Defopharma?
Defopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Defopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0732501933 for Defopharma, if the company is VAT-registered. Its company number (CBE) is 0732.501.933.
Where is the registered office of Defopharma?
According to the CBE register, the registered office of Defopharma is in 7860 Lessines.
What is the equity of Defopharma?
At the close of the 2025 financial year, the equity of Defopharma amounts to 84,881 €, a solvency of 46.8% of total assets.
Who manages Defopharma?
The register lists 1 active mandates at Defopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Defopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →